Conflict of Interest Disclosures for Clinical Practice Guidelines in the National Guideline Clearinghouse

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Norris, Susan L ^a   Holmer, Haley K ^a   Ogden, Lauren A ^a   Selph, Shelley S ^a   Fu, Rongwei ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; INFORMATION SERVICE; INTERPERSONAL COMMUNICATION; JOURNAL IMPACT FACTOR; MEDICAL LITERATURE; PRACTICE GUIDELINE; PUBLICATION; RANDOM SAMPLE; SCIENTIFIC MISCONDUCT;

AUTHORSHIP; CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; FINANCIAL SUPPORT; HUMANS; JOURNAL IMPACT FACTOR; PRACTICE GUIDELINES AS TOPIC;

EID: 84868694131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047343     Document Type: Article

References (44)

1. Thompson DF, (1993) Understanding financial conflicts of interest. N Engl J Med 329: 573-576.
2. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, et al. (2007) A national survey of physician-industry relationships. N Engl J Med 356: 1742-1750.
3. Pharmaceutical Industry Profile 2011 (2011) Washington, DC: Pharmaceutical Research and Manufacturers of America.
4. House of Commons Health Committee (2005) The Influence of the Pharmaceutical Industry, Fourth Report of Session 2004-05. London: House of Commons Health Committee.
5. Bekelman JE, Li Y, Gross CP, (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289: 454-465.
6. Lexchin J, Bero LA, Djulbegovic B, Clark O, (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1170.
7. Stelfox HT, Chua G, O'Rourke K, Detsky AS, (1998) Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338: 101-106.
8. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL, (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290: 921-928.
9. Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, et al. (1994) A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 154: 157-163.
10. Chren MM, Landefeld CS, (1994) Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 271: 684-689.
11. Wang AT, McCoy CP, Murad MH, Montori VM, Wang AT, et al. (2010) Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 340: c1344.
12. Fugh-Berman A, McDonald CP, Bell AM, Bethards EC, Scialli AR, et al. (2011) Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles. PLoS Med 8: e1000425.
13. Barnes DE, Bero LA, (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279: 1566-1570.
14. Institute of Medicine (2011) Clinical Practice Guidelines We Can Trust; Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, editors. Washington, D.C.: The National Academies Press. 197 p.
15. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J, (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318: 527-530.
16. Institute of Medicine (2008) Knowing what works in health care: A roadmap for the nation. Washington, DC: The National Academies Press.
17. Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO, et al. (2008) Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology 71: 57-63.
18. Neuman J, Korenstein D, Ross JS, Keyhani S, (2011) Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 343: d5621.
19. Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN, (2011) Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med 171: 577-584.
20. Choudhry NK, Stelfox HT, Detsky AS, (2002) Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287: 612-617.
21. Taylor R, Giles J, (2005) Cash interests taint drug advice. Nature 437: 1070-1071.
22. Papanikolaou GN, Baltogianni MS, Contopoulos-Ioannidis DG, Haidich AB, Giannakakis IA, et al. (2001) Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Medical Research Methodology 1: 3.
23. Institute of Medicine (2009) Conflict of Interest in Medical Research, Education, and Practice; Lo B, Field MJ, editors. Washington, D.C.: The National Academies Press. 414 p.
24. National Guideline Clearinghouse website. Available: http://www.guideline.gov/about/index.aspx. Accessed 2012 May 7.
25. Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J, (2009) Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines. Psychother Psychosom 78: 228-232.
26. Journal Citation Reports website. Available: www.webofknowledge.com/JCR. Accessed 2011 Sep 23.
27. Tregear M (2007) Guideline Heterogeneity: Workshop Part 2, ECRI Institute, August 27. Presentation at the Fourth Annual Guidelines International Network Meeting, Toronto, August 22-25.
28. Institute of Medicine (2011) Finding What Works in Health Care: Standards for Systematic Reviews; Eden J, Levit L, Berg A, Morton S, editors. Washington, D.C.: The National Academies Press. 245 p.
29. International Committee of Medical Journal Editors (2012) Uniform requirements for manuscripts submitted to biomedical journals. Available: http://www.icmje.org/ethical_4conflicts.html. Accessed 2012 Jul 8.
30. Council of Medical Specialty Societies (2011) Code for Interactions with Companies. Available: http://www.cmss.org/codeforinteractions.aspx. Accessed 2012 Jul 7.
31. Brawley O, Byers T, Chen A, Pignone M, Ransohoff D, et al. (2011) New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines. JAMA: The Journal of the American Medical Association 306: 2495-2499.
32. Coyne DW, (2007) Influence of industry on renal guideline development. Clin J Am Soc Nephrol 2: 3-7.
33. Hietanen P (2009) Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer? Ann Oncol 20: 1749-1751; author reply 1751-1742.
34. Buchan HA, Currie KC, Lourey EJ, Duggan GR, (2010) Australian clinical practice guidelines-a national study. Med J Aust 192: 490-494.
35. Norris SL, Holmer HK, Burda BU, Ogden LA, Fu R, (2012) Conflict of interest policies for organizations producing a large number of clinical practice guidelines. PLoS ONE 7: e37413.
36. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, et al. (2010) Funding of US biomedical research, 2003-2008. JAMA 303: 137-143.
37. Norris S, Holmer H, Ogden L, Burda B, (2011) Conflict of interest in clinical practice guideline development: a systematic review. PLoS ONE 6: e25153.
38. Chimonas S, Frosch Z, Rothman DJ, (2011) From Disclosure to Transparency: The Use of Company Payment Data. Arch Intern Med 171: 81-86.
39. Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M, et al. (2009) Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 361: 1466-1474.
40. Weinfurt KP, Seils DM, Tzeng JP, Lin L, Schulman KA, et al. (2008) Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents. PLOS One 3: e2128.
41. Schunemann HJ, Osborne M, Moss J, Manthous C, Wagner G, et al. (2009) An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med 180: 564-580.
42. Levinsky NG, (2002) Nonfinancial conflicts of interest in research. N Engl J Med 347: 759-761.
43. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, et al. (2010) The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 152: 738-741.
44. Alpert JS, Shine KI, Adams RJ, Antman EM, Kavey RE, et al. (2004) Task force 1: The ACCF and AHA codes of conduct in human subjects research. J Am Coll Cardiol 44: 1724-1728.